Patel Sanj K
CIK 0001532218 Name as filed on the most recent filing
Filed as Patel Sanj K (28)
87 transaction lines · from 28 filings · filed 2012-03-27 to 2026-05-01 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Kiniksa Pharmaceuticals International, plc 15 filings
- ISSUER Synageva Biopharma Corp 13 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
87 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-01 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 48,565 disposed | 54.02 | 2,623,481.30 | Form 4, filing 0001532218-26-000008 | |
| 2026-04-30 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 2,141 disposed | 54.01 | 115,635.41 | Form 4, filing 0001532218-26-000006 | |
| 2026-04-29 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 22,544 disposed | 54.01 | 1,217,601.44 | Form 4, filing 0001532218-26-000006 | |
| 2026-04-28 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 243,596 disposed | 52.02 | 12,671,863.92 | Form 4, filing 0001532218-26-000006 | |
| 2026-04-28 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 113,673 disposed | 51.47 | 5,850,749.31 | Form 4, filing 0001532218-26-000006 | |
| 2026-04-28 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 74,635 disposed | 50.43 | 3,763,843.05 | Form 4, filing 0001532218-26-000006 | |
| 2026-04-28 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 51,750 disposed | 54.02 | 2,795,535.00 | Form 4, filing 0001532218-26-000006 | |
| 2026-04-06 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 7,278 disposed | 50.01 | 363,972.78 | Form 4, filing 0001532218-26-000004 | |
| 2025-10-22 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 97,390 disposed | 38.83 | 3,781,653.70 | Form 4, filing 0001532218-25-000005 | |
| 2025-10-21 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 39,331 disposed | 38.77 | 1,524,862.87 | Form 4, filing 0001532218-25-000005 | |
| 2025-10-20 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 98,934 disposed | 38.81 | 3,839,628.54 | Form 4, filing 0001532218-25-000005 | |
| 2025-10-20 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 22,314 disposed | 39.32 | 877,386.48 | Form 4, filing 0001532218-25-000005 | |
| 2025-05-28 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 62,116 disposed | 27.33 | 1,697,630.28 | Form 4, filing 0001415889-25-014744 | |
| 2025-05-27 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 19,317 disposed | 27.01 | 521,752.17 | Form 4, filing 0001415889-25-014744 | |
| 2025-05-23 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 4,837 disposed | 27.00 | 130,599.00 | Form 4, filing 0001415889-25-014744 | |
| 2025-05-20 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 2,349 disposed | 27.02 | 63,469.98 | Form 4, filing 0001415889-25-014167 | |
| 2025-05-13 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 2,872 disposed | 27.03 | 77,630.16 | Form 4, filing 0001415889-25-013170 | |
| 2025-05-09 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 6,029 disposed | 27.05 | 163,084.45 | Form 4, filing 0001415889-25-012571 | |
| 2025-05-08 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 101 disposed | 27.00 | 2,727.00 | Form 4, filing 0001415889-25-012571 | |
| 2025-05-07 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 1,965 disposed | 27.00 | 53,055.00 | Form 4, filing 0001415889-25-012571 | |
| 2024-11-06 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 89,561 disposed | 23.00 | 2,059,903.00 | Form 4, filing 0001415889-24-026451 | |
| 2024-07-23 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 63,049 disposed | 27.01 | 1,702,953.49 | Form 4, filing 0001415889-24-020108 | |
| 2024-07-23 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 50,000 disposed | 25.05 | 1,252,500.00 | Form 4, filing 0001415889-24-020108 | |
| 2024-07-23 |
Kiniksa Pharmaceuticals International, plc KNSA |
S, Open-market sale | 23,075 disposed | 23.25 | 536,493.75 | Form 4, filing 0001415889-24-020108 | |
| 2024-03-07 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 65,012 disposed | 21.02 | 1,366,552.24 | Form 4, filing 0001415889-24-007569 | |
| 2024-03-06 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 5,582 disposed | 21.00 | 117,222.00 | Form 4, filing 0001415889-24-007083 | |
| 2024-03-04 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 9,406 disposed | 21.31 | 200,441.86 | Form 4, filing 0001415889-24-007083 | |
| 2024-03-04 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 3,336 disposed | 22.00 | 73,392.00 | Form 4, filing 0001415889-24-007083 | |
| 2021-02-10 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 1,600 disposed | 23.06 | 36,896.00 | Form 4, filing 0001179110-21-001553 | |
| 2021-02-10 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 1,137 disposed | 23.07 | 26,230.59 | Form 4, filing 0001179110-21-001553 | |
| 2021-02-09 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 23,569 disposed | 23.08 | 543,972.52 | Form 4, filing 0001179110-21-001553 | |
| 2021-02-09 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 20,401 disposed | 23.04 | 470,039.04 | Form 4, filing 0001179110-21-001553 | |
| 2021-02-08 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 4,924 disposed | 23.00 | 113,252.00 | Form 4, filing 0001179110-21-001553 | |
| 2021-02-08 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 4,528 disposed | 23.00 | 104,144.00 | Form 4, filing 0001179110-21-001553 | |
| 2020-10-12 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 150,700 disposed | 21.02 | 3,167,714.00 | Form 4, filing 0001179110-20-010450 | |
| 2020-10-12 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 99,330 disposed | 21.02 | 2,087,916.60 | Form 4, filing 0001179110-20-010450 | |
| 2020-10-09 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 872 disposed | 21.00 | 18,312.00 | Form 4, filing 0001179110-20-010450 | |
| 2020-10-09 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 670 disposed | 21.00 | 14,070.00 | Form 4, filing 0001179110-20-010450 | |
| 2020-03-06 |
Kiniksa Pharmaceuticals, Ltd. KNSA |
S, Open-market sale | 33,115 disposed | 20.00 | 662,300.00 | Form 4, filing 0001179110-20-003417 | |
| 2014-12-17 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 26,960 disposed | 90.06 | 2,428,017.60 | Form 4, filing 0001246360-14-004749 | |
| 2014-12-17 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 13,536 disposed | 87.55 | 1,185,076.80 | Form 4, filing 0001246360-14-004749 | |
| 2014-12-17 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 5,016 disposed | 87.25 | 437,646.00 | Form 4, filing 0001246360-14-004749 | |
| 2014-12-17 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 4,488 disposed | 87.26 | 391,622.88 | Form 4, filing 0001246360-14-004749 | |
| 2014-01-29 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 24,817 disposed | 87.19 | 2,163,794.23 | Form 4, filing 0001246360-14-000472 | |
| 2014-01-29 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 18,652 disposed | 88.31 | 1,647,158.12 | Form 4, filing 0001246360-14-000472 | |
| 2014-01-29 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 5,600 disposed | 89.27 | 499,912.00 | Form 4, filing 0001246360-14-000472 | |
| 2014-01-29 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 1,502 disposed | 90.85 | 136,456.70 | Form 4, filing 0001246360-14-000472 | |
| 2014-01-29 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 400 disposed | 91.58 | 36,632.00 | Form 4, filing 0001246360-14-000472 | |
| 2014-01-28 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 32,609 disposed | 88.38 | 2,881,983.42 | Form 4, filing 0001246360-14-000472 | |
| 2014-01-28 |
Synageva Biopharma Corp GEVA |
S, Open-market sale | 9,506 disposed | 87.16 | 828,542.96 | Form 4, filing 0001246360-14-000472 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 87
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Patel Sanj K, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001532218
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6